Login
Subscribe
Q&A: Unique Circumstances for Minority Scientists During COVID-19
Q&A: Unique Circumstances for Minority Scientists During COVID-19
Investigators from underrepresented groups have borne the brunt of the disruption to science from the pandemic, according to an opinion piece that outlines ways in which institutions can lessen the damage.
Investigators from underrepresented groups have borne the brunt of the disruption to science from the pandemic, according to an opinion piece that outlines ways in which institutions can lessen the damage.
publishing, disease & medicine
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis
Max Kozlov | Jan 14, 2021 | 5 min read
Few peer-reviewed clinical papers on the pandemic contained original data, and many of those that did had poor experimental design.
Opinion: Scientists in the US and China Collaborating on COVID-19
Jenny J. Lee and John P. Haupt | Jun 22, 2020 | 4 min read
Despite high-profile political tensions between the two countries, researchers in the US and China are working together now more than ever, according to our bibliometric study.
Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere
Catherine Offord | May 30, 2020 | 9 min read
Scientists have raised questions about the dataset published in The Lancet last week that triggered the suspension of clinical trials around the world—and about Surgisphere Corporation, the company behind the study.